The Collective of Experts at Devinebio
Devinebio has assembled a collection of drug development experts. The help us implement the Devine Process that cover activities ranging from early discovery into early clinical development.
We have both internal and external focus for this expert team:
Internal: fostering growth Special Purpose Exit Companies (SPECs). In partnership with Patent Advocacy Group and their advisors, we form a SPEC and use the Collective of Experts team uses the Devine Process to mature drug assets in a given rare disease towards market approval.
External: The Collective of Experts team use the Devine Process to provide efficient drug development solutions for Life Science companies. We aid in commercializing therapeutics for Small Molecules, Biologics and Advanced Therapeutics. The Devine Process accesses expert talent, at the right time, and at the right place of need, to help keep the drug development pipeline on track.
Bottomline, the Collective of Experts provides just-in-time solutions, at the right time and place where they are most needed. Devine Process - providing the accelerated path towards market approval.
Target ID, Drug Discovery, Corporate Relations
iPSC Assay Development, Drug Screens, High Content imaging
Molecular Dynamics Modeling, AI Smart Library Generation
Regulatory Strategy, Drug Development, Health Authority Liaison
Drug Discovery, Neurology and cardiology, Disease Model Creation
Microphysological Systems, Bimedical Engineering, Microfluidics
Immunological Drug Development, Vaccine Therapies in Oncology, iPSC Platforms for Drug Discovery
Priority Review Vouchers, Alternative Funding, Drug Hunting, Startups.
Toxicology Studies, ADME Parameters, Rare Diseases
Neurodegeneration models, drug discovery and development
Patents, IP licensing, Dispute Resolution
Neuropharmacology, biomarker development, Statistics
Microfludics, Neuromuscular Junction Models, iPSC-based Systems
Bioprinting, Vascular 3D models, Venture Architect
Data Managment Services, Statistical Analysis Plans, Strategic Planning
The Collective of Experts team expertise covers Drug-Protein Interaction Modeling, Smart Library Generation, High-throughput and High-content Assay Development, Animal Model Development, FDA Regulatory Filings, Chemistry-Manufacturing-Controls, and Clinical Trials Planning, and more.